On the other side, previous publications reported that CD8+ were more frequent in AR+ than AR− tumours [12, 29, 30], in contrast to our study which showed that neither CD8 nor CD4 were statistically different between AR+ and AR− tumours. Here, CD8A is linked to neoplasm.